219 related articles for article (PubMed ID: 27042052)
1. Design of a novel theranostic nanomedicine: synthesis and physicochemical properties of a biocompatible polyphosphazene-platinum(II) conjugate.
Avaji PG; Park JH; Lee HJ; Jun YJ; Park KS; Lee KE; Choi SJ; Lee HJ; Sohn YS
Int J Nanomedicine; 2016; 11():837-51. PubMed ID: 27042052
[TBL] [Abstract][Full Text] [Related]
2. Design of theranostic nanomedicine (II): synthesis and physicochemical properties of a biocompatible polyphosphazene-docetaxel conjugate.
Jun YJ; Park JH; Avaji PG; Park KS; Lee KE; Lee HJ; Sohn YS
Int J Nanomedicine; 2017; 12():5373-5386. PubMed ID: 28794629
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and properties of a new micellar polyphosphazene-platinum(II) conjugate drug.
Avaji PG; Joo HI; Park JH; Park KS; Jun YJ; Lee HJ; Sohn YS
J Inorg Biochem; 2014 Nov; 140():45-52. PubMed ID: 25061690
[TBL] [Abstract][Full Text] [Related]
4. Design of a Novel Theranostic Nanomedicine (III): Synthesis and Physicochemical Properties of Tumor-Targeting Cisplatin Conjugated to a Hydrophilic Polyphosphazene.
Patil BR; Kang SY; Jung DH; Avaji PG; Jun YJ; Lee HJ; Sohn YS
Int J Nanomedicine; 2020; 15():981-990. PubMed ID: 32103951
[TBL] [Abstract][Full Text] [Related]
5. Synthesis, characterization, and tumor selectivity of a polyphosphazene-platinum(II) conjugate.
Song R; Joo Jun Y; Ik Kim J; Jin C; Sohn YS
J Control Release; 2005 Jun; 105(1-2):142-50. PubMed ID: 15894394
[TBL] [Abstract][Full Text] [Related]
6. Rationally designed oxaliplatin-nanoparticle for enhanced antitumor efficacy.
Paraskar A; Soni S; Roy B; Papa AL; Sengupta S
Nanotechnology; 2012 Feb; 23(7):075103. PubMed ID: 22275055
[TBL] [Abstract][Full Text] [Related]
7. Molecular Engineering of Conjugated Polymers for Biocompatible Organic Nanoparticles with Highly Efficient Photoacoustic and Photothermal Performance in Cancer Theranostics.
Guo B; Sheng Z; Hu D; Li A; Xu S; Manghnani PN; Liu C; Guo L; Zheng H; Liu B
ACS Nano; 2017 Oct; 11(10):10124-10134. PubMed ID: 28892609
[TBL] [Abstract][Full Text] [Related]
8. Selective tumor targeting by enhanced permeability and retention effect. Synthesis and antitumor activity of polyphosphazene-platinum (II) conjugates.
Jun YJ; Kim JI; Jun MJ; Sohn YS
J Inorg Biochem; 2005 Aug; 99(8):1593-601. PubMed ID: 15963570
[TBL] [Abstract][Full Text] [Related]
9. Using Peptide Aptamer Targeted Polymers as a Model Nanomedicine for Investigating Drug Distribution in Cancer Nanotheranostics.
Zhao Y; Houston ZH; Simpson JD; Chen L; Fletcher NL; Fuchs AV; Blakey I; Thurecht KJ
Mol Pharm; 2017 Oct; 14(10):3539-3549. PubMed ID: 28880092
[TBL] [Abstract][Full Text] [Related]
10. Galactose conjugated platinum(II) complex targeting the Warburg effect for treatment of non-small cell lung cancer and colon cancer.
Wu M; Li H; Liu R; Gao X; Zhang M; Liu P; Fu Z; Yang J; Zhang-Negrerie D; Gao Q
Eur J Med Chem; 2016 Mar; 110():32-42. PubMed ID: 26807543
[TBL] [Abstract][Full Text] [Related]
11. Biological characterization of folate-decorated biodegradable polymer-platinum(II) complex micelles.
Wang R; Hu X; Wu S; Xiao H; Cai H; Xie Z; Huang Y; Jing X
Mol Pharm; 2012 Nov; 9(11):3200-8. PubMed ID: 22954154
[TBL] [Abstract][Full Text] [Related]
12. cis-Amminedichloro(2-methylpyridine) platinum(II) (AMD473), a novel sterically hindered platinum complex: in vivo activity, toxicology, and pharmacokinetics in mice.
Raynaud FI; Boxall FE; Goddard PM; Valenti M; Jones M; Murrer BA; Abrams M; Kelland LR
Clin Cancer Res; 1997 Nov; 3(11):2063-74. PubMed ID: 9815598
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics, biodistribution and in vivo efficacy of cisplatin loaded poly(L-glutamic acid)-g-methoxy poly(ethylene glycol) complex nanoparticles for tumor therapy.
Yu H; Tang Z; Zhang D; Song W; Zhang Y; Yang Y; Ahmad Z; Chen X
J Control Release; 2015 May; 205():89-97. PubMed ID: 25529533
[TBL] [Abstract][Full Text] [Related]
14. Enhanced antitumor activity [correction for activitiy] of trans(+/-)-1,2-diaminocyclo- hexaneglutamatoplatinum(II) formulated with stealth liposome.
Han I; Kim OJ; Lee GY; Sung YK; Song R; Sohn YS
Bioorg Med Chem; 2003 Dec; 11(24):5443-7. PubMed ID: 14642589
[TBL] [Abstract][Full Text] [Related]
15. "One-Pot" Fabrication of Highly Versatile and Biocompatible Poly(vinyl alcohol)-porphyrin-based Nanotheranostics.
Luo Y; Wu H; Feng C; Xiao K; Yang X; Liu Q; Lin TY; Zhang H; Walton JH; Ajena Y; Hu Y; Lam KS; Li Y
Theranostics; 2017; 7(16):3901-3914. PubMed ID: 29109786
[TBL] [Abstract][Full Text] [Related]
16. Polymer nanoparticle delivery of dichloroacetate and DACH-Pt to enhance antitumor efficacy and lower systemic toxicity.
Yang Q; Cai J; Sun S; Kang X; Guo J; Zhu Y; Yan L; Jing X; Wang Z
Biomater Sci; 2016 Apr; 4(4):661-9. PubMed ID: 26810463
[TBL] [Abstract][Full Text] [Related]
17. Co-delivery of cisplatin and paclitaxel by folic acid conjugated amphiphilic PEG-PLGA copolymer nanoparticles for the treatment of non-small lung cancer.
He Z; Huang J; Xu Y; Zhang X; Teng Y; Huang C; Wu Y; Zhang X; Zhang H; Sun W
Oncotarget; 2015 Dec; 6(39):42150-68. PubMed ID: 26517524
[TBL] [Abstract][Full Text] [Related]
18. A Lipophilic Pt(IV) Oxaliplatin Derivative Enhances Antitumor Activity.
Abu Ammar A; Raveendran R; Gibson D; Nassar T; Benita S
J Med Chem; 2016 Oct; 59(19):9035-9046. PubMed ID: 27603506
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and cytotoxic activity of dextran carrying cis-dichloro(cyclohexane-trans-l-1,2-diamine)platinum(II) complex.
Ohya Y; Masunaga T; Baba T; Ouchi T
J Biomater Sci Polym Ed; 1996; 7(12):1085-96. PubMed ID: 8880440
[TBL] [Abstract][Full Text] [Related]
20. Preclinical efficacy and pharmacokinetics of AP5346, a novel diaminocyclohexane-platinum tumor-targeting drug delivery system.
Rice JR; Gerberich JL; Nowotnik DP; Howell SB
Clin Cancer Res; 2006 Apr; 12(7 Pt 1):2248-54. PubMed ID: 16609041
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]